Published in Cancer Weekly, January 11th, 2005
This allowance has been granted a than one year after filing. The regulatory process included a certain number of clinical tests conducted in two local medical centers, one being the largest oncology center in Russia.
The Russian market, as some other countries in Central Europe and in Asia, has been identified by IBt as an important commercial target for the forthcoming years.
The company has also entered into a distribution agreement with a Russian company that will promote the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.